A correlation was observed between PARP1 activation, reduced NAD+ levels, and SIRT1 activity inhibition in patients with pigmented keratoses, progeria-like aging, ataxia telangiectasia, and Cockayne syndrome [143]. This evidence concerns the gene PARP1 and Cockayne syndrome.